|
KMID : 0361120150290040238
|
|
Korean Journal of Transplantation
2015 Volume.29 No. 4 p.238 ~ p.241
|
|
|
Kidney Transplant Patient with a Facial Redness
|
|
Jung Jong-Hwan
Jang Jin-Won
Lim Jin-Han
Lee Ja-Yeon
Lee Sik
Yu Hee-Chul
Hwang Hong-Pil
Park Sung-Kwang
|
|
|
Abstract
|
|
|
|
Posttransplant erythrocytosis (PTE) is a common complication of renal transplantation, which can occur in approximately 10% to 15% of renal transplant patients and usually affects males with relatively good renal function. It is also associated with an increased incidence of thromboembolic events. Clinical manifestations of PTE include malaise, headache, plethora, lethargy, and dizziness. It is correlated with use of cyclosporin, gender, posttransplant renal function, and type of antihypertensive medication. The angiotensin receptor blocker (ARB) or angiotensin-converting enzyme inhibitor is preferred as an initial treatment for PTE because these agents are effective and reasonably safe in the majority of patients with PTE, and can also provide a necessary antihypertensive effect for kidney transplant patients. We report here on a 35-year-old male who had erythrocytosis after renal transplantation. After renal transplantation, his level of hemoglobin was 21 g/dL. We treated this patient with ARB and his symptoms and signs have been completely relieved.
|
|
|
KEYWORD
|
|
|
Kidney transplantation, Polycythemia, Angiotensin receptor antagonists
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|